Equities

Jinyu Bio-Technology Co Ltd

600201:SHH

Jinyu Bio-Technology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)6.87
  • Today's Change0.08 / 1.18%
  • Shares traded13.40m
  • 1 Year change-28.44%
  • Beta--
Data delayed at least 15 minutes, as of Jul 05 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.

  • Revenue in CNY (TTM)1.58bn
  • Net income in CNY282.51m
  • Incorporated1993
  • Employees1.65k
  • Location
    Jinyu Bio-Technology Co LtdNo. 58, Ordos West StreetHUHEHAOTE 010111ChinaCHN
  • Phone+86 4 716539434
  • Fax+86 4 718086060
  • Websitehttp://www.jinyu.com.cn
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
North China Pharmaceutical Co Ltd10.02bn17.62m7.31bn10.16k414.801.37--0.72960.01030.01035.843.110.46932.714.31986,082.900.3543-0.29780.8122-0.704230.2635.730.755-0.59850.54251.430.6473---3.621.89100.71-49.624.22-19.73
Jianmin Pharmaceutical Group Co Ltd4.17bn521.42m7.36bn2.50k14.083.13--1.773.413.4127.2615.351.045.814.341,669,960.0013.0910.8723.6619.1143.7043.0412.569.321.26--0.189137.1515.7214.2827.7845.058.7743.10
China Animal Husbandry Industry Co., Ltd5.47bn339.08m7.42bn4.33k21.891.33--1.360.33210.33215.365.480.63314.134.891,264,384.003.336.234.719.0118.9524.295.268.691.86--0.201731.20-8.244.04-26.73-0.612724.20-3.77
Guangxi Wuzhou Zhongheng Group Co Ltd3.23bn156.14m7.70bn2.89k49.101.17--2.380.04540.04540.94131.910.27661.963.411,120,149.000.95422.261.513.3853.6672.053.457.272.38--0.179545.6714.10-1.266.69-32.76-4.56-30.12
Jinyu Bio-Technology Co Ltd1.58bn282.51m7.70bn1.65k26.541.36--4.860.25880.25881.445.050.23652.061.98956,543.204.094.824.795.6857.9758.7817.2819.913.33--0.004336.414.55-3.3734.63-17.77-12.92-25.56
Nanjing Vazyme Biotech Co Ltd1.29bn-15.12m7.77bn2.70k--1.93--6.04-0.0368-0.03683.2710.070.21910.97612.85476,061.10-0.28613.16-0.372415.9271.3170.50-1.3123.922.97--0.215432.20-63.9749.74-111.94--48.61--
Youcare Pharmaceutical Group Co Ltd4.04bn168.83m7.82bn3.18k46.262.14--1.940.37570.37578.978.130.65182.074.091,269,471.002.767.114.1511.6559.5464.144.248.071.42--0.207960.95-7.611.05-44.84-7.1623.40--
Data as of Jul 05 2024. Currency figures normalised to Jinyu Bio-Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

13.80%Per cent of shares held by top holders
HolderShares% Held
GF Fund Management Co., Ltd.as of 30 Sep 202339.05m3.49%
First Seafront Fund Management Co., Ltd.as of 31 Dec 202331.99m2.86%
Guotai Asset Management Co., Ltd.as of 30 Sep 202321.11m1.88%
Bosera Asset Management Co., Ltd.as of 31 Dec 202312.35m1.10%
AXA-SPDB Investment Managers Co., Ltd.as of 31 Dec 202311.80m1.05%
China Asset Management Co., Ltd.as of 31 Dec 20238.79m0.79%
Zhong Ou Asset Management Co., Ltdas of 31 Dec 20237.79m0.70%
Da Cheng Fund Management Co., Ltd.as of 31 Dec 20237.69m0.69%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 20237.57m0.68%
Fullgoal Fund Management Co., Ltd.as of 31 Dec 20236.47m0.58%
More ▼
Data from 31 Dec 2023 - 03 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.